What is AnaptysBio, Inc.'s revenue?

AnaptysBio, Inc. (ANAB) reported revenue of $25.56M in Q1 2026.

How has AnaptysBio, Inc.'s revenue changed year-over-year?

AnaptysBio, Inc.'s revenue decreased by 8.0% year-over-year, from $27.77M to $25.56M.

What is the long-term trend for AnaptysBio, Inc.'s revenue?

Over 4 years (2021 to 2025), AnaptysBio, Inc.'s revenue has grown at a 38.8% compound annual growth rate (CAGR), from $63.18M to $234.6M.

AnaptysBio, Inc. ANAB Revenue

Revenue at other companies

HTF

Heartflow, Inc. Common StockHTFL

$52.59M+41.3%

Cal-Maine FoodsCALM

$666.95M-53.0%

DJT

Trump Media & Technology GroupDJT

$871.2K+6.1%

ADMA BiologicsADMA

$114.49M-0.3%

Minerals TechnologiesMTX

$546.9M+11.2%

Lincoln Educational Services CorporationLINC

$143.96M+22.5%

Other financials

Income statement

See full

Revenue$25.6M-8.0%

Operating income-$34.6M-25.8%

Net income-$52.9M-34.5%

EPS (diluted)-$1.84-43.8%

Balance sheet

See full

Cash & equivalents$248.5M+152%

Total debt$13.6K-99.9%

Total equity$12.7M-62.5%

Total assets$329.7M-21.9%

Cash flow

See full

Operating cash flow-$25.9M-142%

CapEx$17.0K-51.4%

Free cash flow-$25.9M-142%

Valuation

See full

Market cap$1.7B+180%

Profitability

See full

Operating margin17.6%+9.6pp

Net margin-49.9%-22.6pp

FCF margin1.9%+1.0pp

Returns & leverage

See full

Return on equity-343.8%-1,012pp

Debt / equity0×-0.5×

Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AnaptysBio, Inc.'s revenue?: AnaptysBio, Inc. (ANAB) reported revenue of $25.56M in Q1 2026.
How has AnaptysBio, Inc.'s revenue changed year-over-year?: AnaptysBio, Inc.'s revenue decreased by 8.0% year-over-year, from $27.77M to $25.56M.
What is the long-term trend for AnaptysBio, Inc.'s revenue?: Over 4 years (2021 to 2025), AnaptysBio, Inc.'s revenue has grown at a 38.8% compound annual growth rate (CAGR), from $63.18M to $234.6M.